Plasmodium Immunotherapy is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Brain Tumor.

Plasmodium Immunotherapy is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Thyroid Cancer.

chennai super kings captain 2024 Taide Pharmaceutical won the second prize of Beijing Science and Technology Award in 2019 Esophageal cancer immunotherapy! Bristol-Myers Squibb's Opdivo is recommended ...